The effect of CYP2C9*2, CYP2C9*3, and VKORC1-1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah.

The effect of CYP2C9*2, CYP2C9*3, and VKORC1-1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah.

Hosseinkhani, Zohreh; Sadeghalvad, Mona; Norooznezhad, Fathemeh; Khodarahmi, Reza; Fazilati, Mohammad; Mahnam, Azadeh; Fattahi, Ali; Mansouri, Kamran.

Afiliação

Hosseinkhani Z; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Sadeghalvad M; Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.
Norooznezhad F; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Khodarahmi R; Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.
Fazilati M; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Mahnam A; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Fattahi A; Department of Biochemistry, Payam-e Noor University of Isfahan, Isfahan, I.R. Iran.
Mansouri K; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.

Res Pharm Sci ; 13(4): 377-384, 2018 Aug.

Article em En | MEDLINE | ID: mdl-30065771